https://mtor-receptor.com/inde....x.php/value-associat
The 7% action level threshold was not breached. Despite the acceptable TPS performance demonstrated by current benchmarks, certain points of interest exhibited imprecise dose predictions arising from the CC algorithm. Recommendations were given to enhance TPS and linear accelerator control systems in particular locations. Current benchmark data suggests that our TPS is appropriate for clinical use, even though